Volatile Anaesthetics Enhance the Metastasis Related Cellular Signalling Including CXCR2 of Ovarian Cancer Cells

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Mar 31

PMID 27028996

Citations 59

Authors

Masae Iwasaki

Hailin Zhao

Tanweer Jaffer

Sandeep Unwith

Laura Benzonana

Qingquan Lian

Atsuhiro Sakamoto

Daqing Ma

Affiliations

Soon will be listed here.

Abstract

The majority of ovarian cancer patients relapse after surgical resection. Evidence is accumulating regarding the role of surgery in disseminating cancer cells; in particular anaesthesia may have an impact on cancer re-occurrence. Here, we have investigated the metastatic potential of volatile anaesthetics isoflurane, sevoflurane and desflurane on ovarian cancer cells. Human ovarian carcinoma cells (SKOV3) were exposed to isoflurane (2%), sevoflurane (3.6%) or desflurane (10.3%) for 2 hours. Metastatic related gene expression profiles were measured using the Tumour Metastasis PCR Array and qRT-PCR. Subsequently vascular endothelial growth factor A (VEGF-A), matrix metalloproteinase 11 (MMP11), transforming growth factor beta-1 (TGF-β1) and chemokine (C-X-C motif) receptor 2 (CXCR2) proteins expression were determined using immunofluorescent staining. The migratory capacities of SK-OV3 cells were assessed with a scratch assay and the potential role of CXCR2 in mediating the effects of volatile anaesthetics on cancer cell biology were further investigated with CXCR2 knockdown by siRNA. All three volatile anaesthetics altered expression of 70 out of 81 metastasic related genes with significant increases in VEGF-A, MMP-11, CXCR2 and TGF-β genes and protein expression with a magnitude order of desflurane (greatest), sevoflurane and isoflurane. Scratch analysis revealed that exposure to these anesthetics increased migration, which was abolished by CXCR2 knockdown. Volatile anaesthetics at clinically relevant concentrations have strong effects on cancer cell biology which in turn could enhance ovarian cancer metastatic potential. This work raises the urgency for further in vivo studies and clinical trials before any conclusions can be made in term of the alteration of clinical practice.

Citing Articles

Anesthetic Approaches and Their Impact on Cancer Recurrence and Metastasis: A Comprehensive Review.

Choi H, Hwang W Cancers (Basel). 2025; 16(24.

PMID: 39766169 PMC: 11674873. DOI: 10.3390/cancers16244269.

The mechanism of sevoflurane affecting ovarian cancer cell proliferation and migration by regulating RNA methylase TRDMT1 to activate the β-catenin pathway.

Huang X, Lao X, He C, Wang J, Pan Y Cell Biol Toxicol. 2024; 40(1):108.

PMID: 39630363 PMC: 11618209. DOI: 10.1007/s10565-024-09941-x.

Ropivacaine Administration Suppressed A549 Lung Adenocarcinoma Cell Proliferation and Migration via ACE2 Upregulation and Inhibition of the Wnt1 Pathway.

Iwasaki M, Yamamoto M, Tomihari M, Ishikawa M Int J Mol Sci. 2024; 25(17).

PMID: 39273283 PMC: 11395614. DOI: 10.3390/ijms25179334.

Recurrence-free survival after curative resection of non-small cell lung cancer between inhalational gas anesthesia and propofol-based total intravenous anesthesia: a multicenter, randomized, clinical trial (GAS TIVA trial): protocol description.

Kim J, Yoon S, Song I, Lee K, Hwang W, Kim H Perioper Med (Lond). 2024; 13(1):79.

PMID: 39039548 PMC: 11264408. DOI: 10.1186/s13741-024-00436-1.

Personalized anesthesia and precision medicine: a comprehensive review of genetic factors, artificial intelligence, and patient-specific factors.

Zeng S, Qing Q, Xu W, Yu S, Zheng M, Tan H Front Med (Lausanne). 2024; 11:1365524.

PMID: 38784235 PMC: 11111965. DOI: 10.3389/fmed.2024.1365524.

References

Rauh-Hain J, Krivak T, Carmen M, Olawaiye A . Ovarian cancer screening and early detection in the general population. Rev Obstet Gynecol. 2011; 4(1):15-21. PMC: 3100094. View

Wei H, Inan S . Dual effects of neuroprotection and neurotoxicity by general anesthetics: role of intracellular calcium homeostasis. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 47:156-61. PMC: 3791176. DOI: 10.1016/j.pnpbp.2013.05.009. View

Murphy C, McGurk M, Pettigrew J, Santinelli A, Mazzucchelli R, Johnston P . Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res. 2005; 11(11):4117-27. DOI: 10.1158/1078-0432.CCR-04-1518. View

Tavare A, Perry N, Benzonana L, Takata M, Ma D . Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer. 2011; 130(6):1237-50. DOI: 10.1002/ijc.26448. View

Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C . Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 2000; 10(2):165-9. View

Huitink J, Heimerikxs M, Nieuwland M, Loer S, Brugman W, Velds A . Volatile anesthetics modulate gene expression in breast and brain tumor cells. Anesth Analg. 2010; 111(6):1411-5. DOI: 10.1213/ANE.0b013e3181fa3533. View

Christopherson R, James K, Tableman M, Marshall P, Johnson F . Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg. 2008; 107(1):325-32. DOI: 10.1213/ane.0b013e3181770f55. View

Exadaktylos A, Buggy D, Moriarty D, Mascha E, Sessler D . Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?. Anesthesiology. 2006; 105(4):660-4. PMC: 1615712. DOI: 10.1097/00000542-200610000-00008. View

Jamieson T, Clarke M, Steele C, Samuel M, Neumann J, Jung A . Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest. 2012; 122(9):3127-44. PMC: 3428079. DOI: 10.1172/JCI61067. View

10.

Benzonana L, Perry N, Watts H, Yang B, Perry I, Coombes C . Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. Anesthesiology. 2013; 119(3):593-605. DOI: 10.1097/ALN.0b013e31829e47fd. View

11.

Maxwell P, Gallagher R, Seaton A, Wilson C, Scullin P, Pettigrew J . HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene. 2007; 26(52):7333-45. DOI: 10.1038/sj.onc.1210536. View

12.

Luo X, Zhao H, Hennah L, Ning J, Liu J, Tu H . Impact of isoflurane on malignant capability of ovarian cancer in vitro. Br J Anaesth. 2014; 114(5):831-9. DOI: 10.1093/bja/aeu408. View

13.

Lo H, Shieh J, Chen C, Tsou C, Wu W . Vascular endothelial growth factor induces CXCL1 chemokine release via JNK and PI-3K-dependent pathways in human lung carcinoma epithelial cells. Int J Mol Sci. 2013; 14(5):10090-106. PMC: 3676830. DOI: 10.3390/ijms140510090. View

14.

Ishikawa M, Tanaka S, Arai M, Genda Y, Sakamoto A . Differences in microRNA changes of healthy rat liver between sevoflurane and propofol anesthesia. Anesthesiology. 2012; 117(6):1245-52. DOI: 10.1097/ALN.0b013e3182746676. View

15.

Stofas A, Levidou G, Piperi C, Adamopoulos C, Dalagiorgou G, Bamias A . The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma. BMC Cancer. 2014; 14:149. PMC: 4015755. DOI: 10.1186/1471-2407-14-149. View

16.

Ecimovic P, McHugh B, Murray D, Doran P, Buggy D . Effects of sevoflurane on breast cancer cell function in vitro. Anticancer Res. 2013; 33(10):4255-60. View

17.

Bi Q, Tang S, Xia L, Du R, Fan R, Gao L . Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One. 2012; 7(6):e40169. PMC: 3387011. DOI: 10.1371/journal.pone.0040169. View

18.

Camara O, Kavallaris A, Noschel H, Rengsberger M, Jorke C, Pachmann K . Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells. World J Surg Oncol. 2006; 4:67. PMC: 1599731. DOI: 10.1186/1477-7819-4-67. View

19.

Benelli R, Stigliani S, Minghelli S, Carlone S, Ferrari N . Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell. Prostate. 2013; 73(9):941-51. DOI: 10.1002/pros.22640. View

20.

Perigny M, Bairati I, Harvey I, Beauchemin M, Harel F, Plante M . Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer. Am J Clin Pathol. 2008; 129(2):226-31. DOI: 10.1309/49LA9XCBGWJ8F2KM. View